These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12893184)

  • 1. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
    Davidson B; Goldberg I; Reich R; Tell L; Dong HP; Trope' CG; Risberg B; Kopolovic J
    Gynecol Oncol; 2003 Aug; 90(2):248-57. PubMed ID: 12893184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
    Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
    Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B; Reich R; Kopolovic J; Berner A; Nesland JM; Kristensen GB; Tropé CG; Bryne M; Risberg B; van de Putte G; Goldberg I
    Clin Exp Metastasis; 2002; 19(2):135-44. PubMed ID: 11964077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
    Davidson B; Risberg B; Goldberg I; Nesland JM; Berner A; Tropé CG; Kristensen GB; Bryne M; Reich R
    Am J Surg Pathol; 2001 Dec; 25(12):1493-500. PubMed ID: 11717538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma.
    Givant-Horwitz V; Davidson B; van de Putte G; Dong HP; Goldberg I; Amir S; Kristensen GB; Reich R
    Clin Exp Metastasis; 2003; 20(7):599-609. PubMed ID: 14669791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.
    Davidson B; Goldberg I; Tell L; Vigdorchik S; Baekelandt M; Berner A; Kristensen GB; Reich R; Kopolovic J
    Clin Exp Metastasis; 2004; 21(3):191-9. PubMed ID: 15387369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Risberg B; Ben-Baruch G; Reich R
    Cancer Metastasis Rev; 2003 Mar; 22(1):103-15. PubMed ID: 12716042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.
    Davidson B; Reich R; Berner A; Givant-Horwitz V; Goldberg I; Risberg B; Kristensen GB; Trope CG; Bryne M; Kopolovic J; Nesland JM
    Eur J Cancer; 2001 Nov; 37(16):2040-9. PubMed ID: 11597382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
    Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
    Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J
    Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping.
    Sigstad E; Dong HP; Nielsen S; Berner A; Davidson B; Risberg B
    Diagn Cytopathol; 2005 Nov; 33(5):325-31. PubMed ID: 16240402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
    Ahmed N; Riley C; Rice G; Quinn M
    Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
    Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
    Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 expression in ovarian carcinoma is MDR1 independent.
    Davidson B; Goldberg I; Givant-Horwitz V; Nesland JM; Berner A; Bryne M; Risberg B; Kopolovic J; Kristensen GB; Tropé CG; van de Putte G; Reich R
    Am J Clin Pathol; 2002 Feb; 117(2):225-34. PubMed ID: 11863219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
    Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA
    Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.
    Davidson B; Givant-Horwitz V; Lazarovici P; Risberg B; Nesland JM; Trope CG; Schaefer E; Reich R
    Clin Exp Metastasis; 2003; 20(7):621-31. PubMed ID: 14669793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
    Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R
    Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
    Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.